All news

BofA lifts HCA price target to $500, keeps Neutral

Alpha Vantage · Investing.com · · AI-summarised by FinFlash

BofA Securities raised its HCA Healthcare price target to $500 from $450 while keeping a Neutral rating, citing strong execution and upside from supplemental Medicaid programs. HCA's third-quarter EBITDA beat consensus and prompted updated guidance, though Medicaid program cuts and a tougher payor mix remain near-term headwinds.

Read original source

HCA company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.